BioCentury
ARTICLE | Company News

Gene Techno Science, Kaken deal

July 9, 2007 7:00 AM UTC

Gene Techno granted Kaken an exclusive, worldwide license to develop, manufacture and market antibodies that target integrin alpha(9). The companies will collaborate on preclinical R&D of the antibod...